ATE248856T1 - Derivate von glycopeptid-antibiotika - Google Patents

Derivate von glycopeptid-antibiotika

Info

Publication number
ATE248856T1
ATE248856T1 AT00200988T AT00200988T ATE248856T1 AT E248856 T1 ATE248856 T1 AT E248856T1 AT 00200988 T AT00200988 T AT 00200988T AT 00200988 T AT00200988 T AT 00200988T AT E248856 T1 ATE248856 T1 AT E248856T1
Authority
AT
Austria
Prior art keywords
derivatives
glycopeptide antibiotics
glycopeptide
antibiotics
mixed
Prior art date
Application number
AT00200988T
Other languages
English (en)
Inventor
Robin David Grey Cooper
Bret Eugene Huff
Thalia Ioanna Nicas
John Thomas Quatroche
Michael John Rodriguez
Nancy June Snyder
Michael Alexander Staszak
Richard Craig Thompson
Stephen Charles Wilkie
Mark James Zweifel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE248856T1 publication Critical patent/ATE248856T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT00200988T 1994-01-28 1995-01-25 Derivate von glycopeptid-antibiotika ATE248856T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18939394A 1994-01-28 1994-01-28
US35641394A 1994-12-15 1994-12-15

Publications (1)

Publication Number Publication Date
ATE248856T1 true ATE248856T1 (de) 2003-09-15

Family

ID=26885101

Family Applications (3)

Application Number Title Priority Date Filing Date
AT00201724T ATE266042T1 (de) 1994-01-28 1995-01-25 Derivate von glycopeptid-antibiotika
AT95300429T ATE253077T1 (de) 1994-01-28 1995-01-25 Glycopeptid-antibiotika-derivate
AT00200988T ATE248856T1 (de) 1994-01-28 1995-01-25 Derivate von glycopeptid-antibiotika

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT00201724T ATE266042T1 (de) 1994-01-28 1995-01-25 Derivate von glycopeptid-antibiotika
AT95300429T ATE253077T1 (de) 1994-01-28 1995-01-25 Glycopeptid-antibiotika-derivate

Country Status (30)

Country Link
US (1) US5843889A (de)
EP (3) EP0667353B1 (de)
JP (1) JP3756539B2 (de)
KR (1) KR100388867B1 (de)
CN (1) CN1071334C (de)
AT (3) ATE266042T1 (de)
AU (1) AU703106B2 (de)
BR (1) BR9500365A (de)
CA (3) CA2546625C (de)
CO (1) CO4600679A1 (de)
CZ (2) CZ292895B6 (de)
DE (3) DE69533004T2 (de)
DK (3) DK0667353T3 (de)
EG (1) EG25884A (de)
ES (3) ES2204444T3 (de)
FI (3) FI117095B (de)
HU (1) HU225164B1 (de)
IL (1) IL112457A (de)
MY (1) MY128335A (de)
NO (1) NO323103B1 (de)
NZ (1) NZ270387A (de)
PE (1) PE40996A1 (de)
PL (1) PL180961B1 (de)
PT (3) PT667353E (de)
RU (1) RU2145609C1 (de)
SG (1) SG52719A1 (de)
SI (2) SI1016670T1 (de)
TW (1) TW457248B (de)
UA (1) UA43323C2 (de)
YU (1) YU4995A (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5952466A (en) * 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5939382A (en) * 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
ID18900A (id) * 1996-11-21 1998-05-20 Lilly Co Eli Alkilasi menurun dari gliko peptida anti biotik
US5952310A (en) * 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
US5919771A (en) * 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
US5977063A (en) * 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
US5994297A (en) * 1997-08-22 1999-11-30 Eli Lilly And Company Therapy for Staphylococcus aureus
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
ATE361931T1 (de) 1998-05-01 2007-06-15 Lilly Co Eli N1 modifizierte glycopeptide
US6710168B1 (en) 1999-05-19 2004-03-23 The Trustees Of The University Of Princeton Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
JP2002520422A (ja) * 1998-07-14 2002-07-09 プリンストン ユニバーシティ グリコペプチド抗生物質、グリコペプチド抗生物質のコンビナトリアルライブラリーおよびその作成方法
CZ301184B6 (cs) 1998-12-23 2009-12-02 Theravance, Inc. Glykopeptidový derivát a farmaceutické prostredky, které jej obsahují
AU2001257163A1 (en) * 2000-04-25 2001-11-07 Merck And Co., Inc. Glycopeptide antibacterial compounds and methods of using same
US6858584B2 (en) 2000-05-02 2005-02-22 Theravance, Inc. Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
US6770621B2 (en) 2000-05-02 2004-08-03 Theravance, Inc. Polyacid glycopeptide derivatives
EP1276759B1 (de) * 2000-05-02 2008-07-30 Theravance, Inc. Verfahren zur reduktiven alkylierung von glykopeptiden
WO2001098329A1 (en) 2000-06-22 2001-12-27 Theravance, Inc. Polyhydroxy glycopeptide derivatives
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
WO2001098327A2 (en) 2000-06-22 2001-12-27 Theravance, Inc. Glycopeptide carboxy-saccharide derivatives
TWI233932B (en) * 2001-08-24 2005-06-11 Theravance Inc Process for purifying glycopeptide phosphonate derivatives
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
WO2004019970A2 (en) * 2002-08-30 2004-03-11 K.U. Leuven Research And Development Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents
US20050013854A1 (en) 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
EP1641480A1 (de) 2003-05-27 2006-04-05 Theravance, Inc. Verwendung eines antimykotischen polyen-makrolids in kombination mit einem antibakteriellen glycopeptid-mittel
ES2298821T3 (es) 2003-07-22 2008-05-16 Theravance, Inc. Utilizacion de un agente antifungico de equinocandina en combinacion con un agente antibacteriano glicopeptidico.
KR20070092719A (ko) * 2004-11-29 2007-09-13 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 글리코펩타이드 항생 물질 모노머 유도체
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
EP1877611B1 (de) 2005-04-01 2016-11-30 Buckeye Technologies Inc. Vliesstoff für schalldämmung und herstellungsverfahren
CA2623239C (en) 2005-09-22 2016-07-12 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
JP5192384B2 (ja) 2005-09-22 2013-05-08 メディバス エルエルシー ビス−（α−アミノ）−ジオール−ジエステル含有ポリ（エステルアミド）およびポリ（エステルウレタン）組成物および使用の方法
TW200808818A (en) * 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
KR20100109934A (ko) 2007-12-26 2010-10-11 시오노기세야쿠 가부시키가이샤 글리코펩티드 항생 물질 배당화 유도체
CN102083862A (zh) 2008-04-01 2011-06-01 康奈尔大学 有机-可溶性壳聚糖盐和由其制备的壳聚糖衍生生物材料
CN101343313B (zh) * 2008-09-03 2011-11-16 南京农业大学 一种葡萄糖二肽类化合物及其制备方法和用途
ES2741282T3 (es) 2011-05-05 2020-02-10 Matinas Biopharma Nanotechnologies Inc Composiciones de cocleato y métodos de elaboración y uso de las mismas
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.
CN104418941B (zh) * 2013-08-19 2017-11-07 爱斯医药科技(南京)有限公司 万古霉素衍生物、制备方法及其应用
CA2925005A1 (en) 2013-09-23 2015-03-26 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Vancomycin-sugar conjugates and uses thereof
EP3169345A4 (de) 2014-07-17 2018-01-17 The Medicines Company Hochreines oritavancin und verfahren zur herstellung davon
HUE049857T2 (hu) 2014-11-06 2020-10-28 Xellia Pharmaceuticals Aps Glikopeptid-készítmények
CA2972276A1 (en) * 2014-12-25 2016-06-30 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Glycopeptides and uses thereof
CN106188243B (zh) * 2015-05-05 2020-06-26 博瑞生物医药（苏州）股份有限公司 一种奥利万星的制备方法
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN107434823B (zh) * 2016-05-26 2021-11-16 江苏恒瑞医药股份有限公司 一种奥利万星中间体a82846b的纯化方法
CN108409837B (zh) * 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用
CN109053864B (zh) * 2018-07-10 2021-08-24 丽珠集团新北江制药股份有限公司 一种制备奥利万星的方法
CN109053865B (zh) * 2018-07-20 2021-04-13 丽珠集团新北江制药股份有限公司 一种羧基保护制备奥利万星的方法
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation
US3338786A (en) * 1966-07-29 1967-08-29 American Cyanamid Co Antibiotic av290 and production thereof
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
IT1173329B (it) * 1984-02-21 1987-06-24 Lepetit Spa Procedimento per la trasformazione quantitativa di teicoplanina a2 fattore 1 in teicoplanina a2 fattore 3
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
IL78597A0 (en) * 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
US4639433A (en) * 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
US4946941A (en) * 1986-01-24 1990-08-07 Shionogi & Co., Ltd. Novel glycopeptide antibiotics
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
GB8701872D0 (en) * 1987-01-28 1987-03-04 Lepetit Spa N15-alkyl & n15,n15-dialkyl derivatives
US5071749A (en) * 1987-04-16 1991-12-10 Shionogi & Co., Ltd. Glycopetide antibiotic pa-45052-b
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
PT90366A (pt) * 1988-04-28 1989-11-10 Beecham Group Plc Processo para a producao de compostos glicopeptidicos
CA1339808C (en) * 1988-10-19 1998-04-07 Manuel Debono Glycopeptide antibiotics
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
US5185320A (en) * 1989-04-03 1993-02-09 Gruppo Lepetit S.P.A. O56 -alkyl derivatives of aglycone and pseudo aglycones of teicoplanin
DE69001241T2 (de) * 1989-12-11 1993-07-22 De Beers Ind Diamond Schleifprodukte.
CA2031803C (en) * 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
US5187082A (en) * 1990-08-16 1993-02-16 Eli Lilly And Company Process for producing A83850 antibiotics
CA2109601C (en) * 1991-07-29 2002-07-02 Adriano Malabarba Amide derivatives of antibiotic a 40926

Also Published As

Publication number Publication date
EP0667353A1 (de) 1995-08-16
AU1138995A (en) 1995-08-10
SG52719A1 (en) 1998-09-28
US5843889A (en) 1998-12-01
FI20050513A (fi) 2005-05-13
EP1016670A1 (de) 2000-07-05
CA2141106C (en) 2007-01-23
YU4995A (sh) 1998-07-10
CZ292921B6 (cs) 2004-01-14
CA2546625A1 (en) 1995-07-29
ES2210274T3 (es) 2004-07-01
EP0667353B1 (de) 2003-10-29
HU225164B1 (en) 2006-07-28
DE69532013D1 (de) 2003-12-04
DE69533004T2 (de) 2005-04-07
CA2546910A1 (en) 1995-07-29
DE69533004D1 (de) 2004-06-09
DE69531709D1 (de) 2003-10-09
DK1031576T3 (da) 2004-08-16
NO323103B1 (no) 2007-01-02
PE40996A1 (es) 1996-10-14
PL180961B1 (pl) 2001-05-31
PT667353E (pt) 2004-03-31
EG25884A (en) 2012-09-24
RU95101039A (ru) 1996-10-27
PT1031576E (pt) 2004-08-31
DE69532013T2 (de) 2004-07-08
AU703106B2 (en) 1999-03-18
CN1071334C (zh) 2001-09-19
HUT68715A (en) 1995-07-28
IL112457A0 (en) 1995-03-30
FI950374A0 (fi) 1995-01-27
IL112457A (en) 2004-06-20
CO4600679A1 (es) 1998-05-08
BR9500365A (pt) 1995-10-17
MY128335A (en) 2007-01-31
JPH07258289A (ja) 1995-10-09
CA2546910C (en) 2010-09-14
EP1016670B1 (de) 2003-09-03
EP1031576B1 (de) 2004-05-06
FI20050512A (fi) 2005-05-13
FI950374A (fi) 1995-07-29
DK0667353T3 (da) 2004-03-22
HU9500230D0 (en) 1995-03-28
EP1031576A2 (de) 2000-08-30
RU2145609C1 (ru) 2000-02-20
ES2220335T3 (es) 2004-12-16
FI117095B (fi) 2006-06-15
EP1031576A3 (de) 2000-12-27
NO950298L (no) 1995-07-31
PL306976A1 (en) 1995-08-07
FI117097B (fi) 2006-06-15
UA43323C2 (uk) 2001-12-17
ES2204444T3 (es) 2004-05-01
ATE266042T1 (de) 2004-05-15
TW457248B (en) 2001-10-01
CA2546625C (en) 2008-09-09
CZ18495A3 (en) 1995-08-16
DK1016670T3 (da) 2004-01-05
PT1016670E (pt) 2003-12-31
DE69531709T2 (de) 2004-07-15
KR100388867B1 (ko) 2003-10-08
SI1016670T1 (en) 2004-02-29
FI117096B (fi) 2006-06-15
NZ270387A (en) 1996-11-26
NO950298D0 (no) 1995-01-26
KR950032274A (ko) 1995-12-20
JP3756539B2 (ja) 2006-03-15
CZ292895B6 (cs) 2003-12-17
ATE253077T1 (de) 2003-11-15
CA2141106A1 (en) 1995-07-29
CN1119649A (zh) 1996-04-03
SI0667353T1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
DE69531709D1 (de) Derivate von Glycopeptid-Antibiotika
GB2238962B (en) Dual source intravenous adminstration set having an intravenous pump
DE3782720D1 (de) Glykopeptid-antibiotika.
NO895160L (no) Mikrobiell fremgangsmaate for fremstilling av immunhemmende antibiotika.
DE3780644D1 (de) Glykopeptid-antibiotika.
RU95101041A (ru) Липосомные растворы
DE69010924D1 (de) Antibiotikum L53-18A und dessen Herstellung.
ATE66610T1 (de) Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako- kosmetische kompositionen.
IT1207578B (it) Antibiotici carbapenem e relativo procedimento di preparazione.
DK387287D0 (da) Glycopeptidantibiotika
TR199701334T1 (xx) Antibakteriyel antibiyotikler.
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1016670

Country of ref document: EP